Back

Direct inhibitors of factor XI/XIa: where are we now?

31 August 2026 (08:15 - 08:33)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: what is new and what is to come? Treatment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Bianca Rocca

LUM University, Casamassima (Italy)

4 More presentations in this session

Presentation thumbnail
Left atrial appendage closure: integrating opposing trials
Professor U. Landmesser (Berlin, DE)
Slides Video
Presentation thumbnail
Antiarrhythmic drugs: any news yet?
Professor U. Ravens (Freiburg, DE)
Slides Video
Presentation thumbnail
Artificial intelligence-driven population screening for atrial fibrillation: ready for prime time?
Doctor P. Noseworthy (Rochester, US)
Slides Video
Presentation thumbnail
Atrial fibrillation: what is new and what is to come? - discussion
Video

Access the full session

Session thumbnail
Atrial fibrillation: what is new and what is to come?
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation
26 August 2023
thumbnail
Congress Presentation
New therapeutic targets for secondary prevention after ischaemic stroke: factor XIa inhibition and inflammation
30 August 2026
thumbnail
Congress Presentation
Activated factor XI is associated with recurrent venous thromboembolism in patients following pulmonary embolism: a cohort study
29 August 2026
thumbnail
Congress Presentation
Discussant review - LIBREXIA ACS
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources